Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Workman

Showing results (191-200 of 315) with videos related to

Pageof 32
Sort By:
Nucleic Acids Research|October 21, 2022
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and useAlbert A Antolin, Domenico Sanfelice, Alisa Crisp, et al.
Investigational New Drugs|August 5, 2010
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanomaSimon Pacey, Martin Gore, David Chao, et al.
Organic & Biomolecular Chemistry|January 26, 2007
Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycinChristopher S P McErlean, Nicolas Proisy, Christopher J Davis, et al.
Chemistry & Biology|November 23, 2006
Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicolNicolas Proisy, Swee Y Sharp, Kathy Boxall, et al.
Cancer Research|June 17, 2010
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopyNada M S Al-Saffar, L Elizabeth Jackson, Florence I Raynaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancyBeatrice M Seddon, Geoffrey S Payne, Laura Simmons, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2008
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 28, 2010
Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studiesJames E H Day, Swee Y Sharp, Martin G Rowlands, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
EMBO Reports|January 12, 2008
A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral buddingHarold B J Jefferies, Frank T Cooke, Parmjit Jat, et al.
Pageof 32

Showing results (191-200 of 315) with videos related to

Sort By:
Pageof 32
Nucleic Acids Research|October 21, 2022
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and useAlbert A Antolin, Domenico Sanfelice, Alisa Crisp, et al.
Investigational New Drugs|August 5, 2010
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanomaSimon Pacey, Martin Gore, David Chao, et al.
Organic & Biomolecular Chemistry|January 26, 2007
Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycinChristopher S P McErlean, Nicolas Proisy, Christopher J Davis, et al.
Chemistry & Biology|November 23, 2006
Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicolNicolas Proisy, Swee Y Sharp, Kathy Boxall, et al.
Cancer Research|June 17, 2010
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopyNada M S Al-Saffar, L Elizabeth Jackson, Florence I Raynaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancyBeatrice M Seddon, Geoffrey S Payne, Laura Simmons, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2008
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 28, 2010
Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studiesJames E H Day, Swee Y Sharp, Martin G Rowlands, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
EMBO Reports|January 12, 2008
A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral buddingHarold B J Jefferies, Frank T Cooke, Parmjit Jat, et al.
Pageof 32